Type of Posting: General Announcement
Posting Date: 17-Nov-2023
Expert Committee: Small Molecules 4
On the basis of comments received to date, USP is extending the comment deadline for the Pharmacopeial Forum (PF) 49(5) revision proposal for 〈823〉 Positron Emission Tomography Drugs for Compounding, Investigational, and Research Uses and 〈1823〉 Positron Emission Tomography Drugs—Information by sixty days to January 31, 2024.
The purpose of this extension is to allow interested stakeholders ample time to evaluate the proposed changes and submit comments to USP. Please note that when a commenter attempts to send comments or questions through PF after November 30, 2023, a text box will appear in the comment form stating that the comment period has closed for PF 49(5). Please disregard this statement and continue submitting comments or questions through the comment form.
Please contact Gerald Hsu, Ph.D. at gdh@usp.org, if you have any questions.